Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PAHC Stock Forecast, Price Targets, Chart, Dividends & Analysis

Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

23.49
 
USD
  
0.60
  
(2.62%)
Previous close: 22.89  Open: 22.97  Bid: 22.93  Ask: 25.43
52 week range    
9.40   
   24.02
Mkt Cap: 891 M  Avg Vol (90 Days): 182,078
Peers   
HSKA / 
ADM / 
ZTS / 
ICCC / 
MRK / 
Last updated: Sunday 13th October 2024

Stock Rankings

76
MarketXLS Rank
80
Value
92
Technical
57
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ADM

0.034528 B10.8257.97

HSKA

119.99

ICCC

0 B-73.61

LLY

0.0056868 B116.3932.06

MRK

0.0281275 B20.04109.73

ZTS

0.009185 B36.2190.08
Financials

PAHC Income Statement

Annual
Jun-14Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22Jun-23
Amortization of intangibles-5 M-5 M-6 M-6 M-6 M27 M53 M53 M53 M53 M
Basic EPS from continuing operations1.350.831.341.210.81
Basic EPS total-0.11.552.111.631.611.350.831.341.210.81
Basic weighted shares outstanding32193.039 M39 M39524.040181.040412.040454.040473.041 M41 M
Cost of sales-487 M-515 M-512 M-516 M-553 M563 M543 M562 M657 M680 M
Depreciation-21 M-22 M-23 M-26 M-27 M28 M32 M32 M33 M34 M
DepreciationAndAmortization-21 M-22 M-23 M-26 M-27 M28 M32 M32 M33 M34 M
Diluted EPS total-0.11.512.071.611.611.350.831.341.210.81
Diluted normalized net income/share1.350.831.341.210.81
Diluted weighted shares outstanding32193.040 M40 M40042.040385.040523.040504.040504.041 M41 M
Dividends paid per share0.820.40.40.40.40.460.480.480.48
Earnings from equity interest16 M16 M16 M-19 M-19 M-19 M
EarningsFromEquityInterestNetOfTax16 M16 M16 M-19 M-19 M-19 M
GainOnSaleOfBusiness-2 M
GainOnSaleOfSecurity-2 M1 M
GeneralAndAdministrativeExpense-7 M-7 M-8 M-8 M-33 M181 M188 M197 M206 M226 M
Gross operating profit204 M233 M239 M248 M267 M265 M257 M271 M285 M298 M
ImpairmentOfCapitalAssets-2 M-2 M1 M1 M1 M1 M1 M
Income before tax6 M79 M77 M81 M88 M72 M56 M66 M72 M54 M
Income restructuring and M&A-613000.0-1 M-1 M-1 M425000.0
Income taxes9 M18 M-6 M16 M23 M17 M22 M12 M23 M21 M
Interest income119000.0-249000.0256000.02 M2 M2 M2 M838000.0816000.03 M
InterestExpenseNonOperating33 M-15 M-17 M-17 M-14 M12 M14 M12 M12 M18 M
MinorityInterests262 M283 M
MiscOtherSpecialCharges-23 M-3 M820 M16 M
Net income from total operations-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetIncomeCommonStockholders-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetIncomeContinuousOperations-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
NetNonOperatingInterestIncomeExpense-33 M14 M17 M-15 M12 M-12 M-13 M-13 M-12 M-15 M
NetOperatingInterestIncomeExpense33 M-14 M-17 M-15 M-12 M
Normalized income54 M58 M47 M
Operating income64 M88 M86 M98 M-721 M83 M69 M75 M79 M72 M
Operating income before depreciation (EBITDA)62 M87 M84 M91 M102 M112 M102 M110 M117 M106 M
OperatingExpense144 M146 M153 M150 M168 M181 M188 M197 M206 M226 M
Other income net23 M-521000.0-17 M3 M-820 M-18 M19 M264000.0-1 M3 M
Other special charges-2 M
OtherGandA-7 M-7 M-8 M-8 M-33 M181 M188 M197 M206 M226 M
OtherImpairmentOfCapitalAssets-2 M
OtherOperatingExpenses-7 M-3 M-8 M-1 M-2 M-6 M-11 M-2 M-5 M-2 M
OtherWriteOff226000.0-67000.0-96000.0-122000.0-2 M-428000.0264000.0180000.03 M
RentAndLandingFees-7 M-7 M-8 M-8 M-8 M9 M
Research & development expense-8 M-10 M-11 M-9 M-10 M12 M14 M18 M21 M24 M
ResearchExpense12 M14 M18 M21 M24 M
RestructringAndMnAIncome-613000.0-1 M-1 M-1 M425000.0
Revenue per share-5 M-6 M-7 M-7 M-7 M28 M54 M54 M54 M54 M
SalariesAndWages-3 M-4 M-4 M-2 M-334000.02 M-517000.0-1 M-1 M705000.0
Selling Gen & administrative expense144 M146 M153 M150 M168 M181 M188 M197 M206 M226 M
SellingAndMarketingExpense144 M146 M153 M150 M168 M
SellingExpense144 M146 M153 M150 M168 M
Special income/charges613000.01 M4 M3 M-1 M-1 M-1 M-1 M-1 M
Total Income available for interest expense (EBIT)39 M64 M60 M64 M74 M83 M69 M78 M84 M72 M
Total common shares outstanding39 M39 M39 M40 M40 M40 M40 M41 M41 M41 M
Total net income-3 M60 M83 M65 M65 M55 M34 M54 M49 M33 M
Total ordinary shares20 M20 M20 M20 M20 M20 M20 M20 M20 M20 M
Total revenues692 M749 M752 M764 M820 M828 M800 M833 M942 M978 M
TotalExpenses-344 M-370 M-359 M-366 M-385 M745 M731 M758 M863 M906 M
TotalRevenue692 M749 M752 M764 M820 M828 M800 M833 M942 M978 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University